Navigation Links
Prime Therapeutics Becomes First PBM to Join the Center for Health Value Innovation
Date:1/30/2008

ST. PAUL, Minn., Jan. 30 /PRNewswire/ -- Prime Therapeutics (Prime) has joined the Center for Health Value Innovation as the first participant from the pharmacy benefit manager (PBM) industry. The Center for Health Value Innovation is a non-profit organization that collaborates with leading organizations to develop and promote innovative value-based health strategies with the end goal of improving the health of employees. Members of the Center represent various sectors of health care such as health plans, providers and employers.

Prime joined the Center for Health Value Innovation to provide additional support and value to its clients in their development of value-based health strategies. The new membership provides Prime and Prime's clients with additional exposure and access to other industry thought leaders and best practices. "Prime welcomes this opportunity to discuss effective tools and techniques surrounding value-based health strategies with others who share Prime's philosophy of putting the patient's health first," stated Christine Solberg, Assistant Vice President, Clinical Products and Benefit Strategy for Prime.

David Hom, Chairman of the Board for the Center, said, "The Center was established to provide a concept studio for learning and sharing the evidence of success of value-based designs. Prime came to an early workshop, learned from other innovators and moved quickly to join the work of innovating to improve health and reduce cost inflation."

"We are delighted to welcome Prime Therapeutics to our distinguished panel of innovators," said Center President Cyndy Nayer. "Prime has listened to the client needs for both value and improved health status."

Prime views value-based benefit design as an important tool to help PBMs and health plans ensure that their messages to members are aligned. "On one hand, the industry has been saying 'take your medications' while on the other hand, saying 'pay more for the medication you take'," stated Solberg. "Through value-based design, plan sponsors are aligning their messages by providing essential drugs at lower cost to those who benefit the most."

As a Center advisor, Solberg will be participating in the Health and Human Capital Conference to share Prime's philosophy on value-based benefit design on January 31, 2008 in Washington, D.C.

Prime is proactive and innovative in developing new ways to ensure members receive the highest quality of care at the lowest overall costs to members and plan sponsors. Prime's unique relationship with Blue's Plans allows for a unique integration of best in class medical and pharmaceutical management programs to align messages, reduce administrative costs and improve health outcomes.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing, innovative, clinically-based, cost effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 10 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Health Capital Group Warns of Fallout to Hospitals From the Subprime Mortgage Crisis and Urges Hospitals to Immediately Reassess Existing Debt Structures and Capital Financing Plans
2. MDS Issues MDS US GAAP Primer
3. Fetal Alcohol Exposure May Prime Offspring for Alcoholism
4. Safety Concerns Prompt Prime to Remove Avandia(R) from Formulary
5. Announcing Prime Vendor Contract with LIHPA
6. Activist Groups Plea to Indian Prime Minister: Rollout Second-Line AIDS Treatment!
7. Prime Healthcare Services Acquires Centinela Hospital Medical Center
8. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
9. Prime Minister views innovative health technology at Imperial College London
10. Prime Therapeutics Announces URAC Accreditation
11. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... July 27, 2017 , ... Healthy eating isn’t always easy. Currently, more than 80 percent ... time, many Americans overeat refined grains and sugar. This trend may help explain why the ... the U.S. are obese. , As a culture, we seem to have food on the ...
(Date:7/27/2017)... ... July 27, 2017 , ... Cremations recently surpassed traditional ... Directors Association, this trend is expected to continue with over 70% of Americans projected ... growing demand for new innovations that enable families to celebrate the life of a ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: Ashley D. Beall, ... in drug therapy for patients living with relapsing and primary multiple sclerosis that ... cell targeted therapy that has been proven to significantly reduce signs of disease ...
(Date:7/26/2017)... ... ... It may be hard to imagine that the basic necessities that developed countries ... that many developed countries consider rare or eradicated, like measles, are still a rite ... an upcoming segment of "Success Files", actor Rob Lowe will introduce a new segment ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... the cloud ; today announced the availability of its latest data protection solution ... use control console for Data Discovery, Classification, Encryption and Digital Rights Management; GTB ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... 2017 RK Logistics Group, Inc. was awarded ... its Fremont, CA headquarters facility where ... and San Jose for hi-tech, pharmaceutical ... , with its Fremont Innovation District, is excited to ... powerful resource to the hundreds of biotech, pharma and biomed ...
(Date:7/12/2017)... 12, 2017  Eli Lilly and Company (NYSE: ... companies to resolve pending patent litigation in the U.S. District ... regarding the Cialis ® (tadalafil) unit dose patent. ... 2020. As part of the agreement, Cialis exclusivity is now ... "The unit dose patent for Cialis is valid ...
(Date:7/11/2017)... Md. , July 11, 2017  The global ... estimated revenues of approximately $394.1 million in 2016.  Although ... trend of solid growth, in particular as a result ... clinical practice, and the recent introduction of a significant ... need for less-invasive testing of tumor biomarkers to guide ...
Breaking Medicine Technology: